Home > Boards > US Listed > Medical - Drugs > Horizon Pharma, Inc. (HZNP)

News: $HZNP Horizon Therapeutics plc Reports Strong Second-Quarter

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 58
Posts 7,611
Boards Moderated 0
Alias Born 06/04/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/24/2020 6:01:02 PM
Horizon Therapeutics plc to Present at the Cowen and Company 40th Annual Health Care Conference Business Wire - 2/18/2020 8:30:00 AM
Horizon Therapeutics plc Announces U.S. FDA Approval of New Dosage Form for PROCYSBI® (Cysteamine Bitartrate) Delayed-Releas... Business Wire - 2/18/2020 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2020 3:07:55 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2020 8:03:55 AM
Uplifting Athletes Announces Horizon Therapeutics plc as Exclusive Sponsor to Help Tackle Rare Disease at the National Footba... Business Wire - 2/11/2020 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2020 11:52:41 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/4/2020 4:14:59 PM
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2019 Financial Results and Host Webcast on Feb. 26, 2020 Business Wire - 2/4/2020 8:00:00 AM
Horizon Therapeutics Announces Significant Expansion and Relocation of U.S. Operations Business Wire - 1/28/2020 11:10:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/24/2020 4:48:51 PM
Horizon Therapeutics plc Announces Changes in Research and Development Organization Business Wire - 1/24/2020 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:25:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:24:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:23:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:22:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:21:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:19:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:18:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:17:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:16:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2020 4:15:18 PM
The New England Journal of Medicine Publishes Comprehensive Data from Phase 3 Clinical Trial (OPTIC) of TEPEZZA™ (teprotumu... Business Wire - 1/22/2020 5:20:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/21/2020 5:30:35 PM
whytestocks   Wednesday, 08/07/19 01:40:58 PM
Re: None
Post # of 682 
News: $HZNP Horizon Therapeutics plc Reports Strong Second-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance

-- Second-Quarter 2019 Net Sales of $320.6 Million Increased 6 Percent; Second-Quarter 2019 GAAP Net Loss of $5.1 Million; Adjusted EBITDA of $124.1 Million -- -- Quarterly Orphan and Rheumatology Segment Net Sales Increased 11 Percent to $223.5 Million; KRYSTEXXA ® Second-Quar...

Read the whole news Horizon Therapeutics plc Reports Strong Second-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist